Pfizer is pushing to be more involved in cancer drugs after a turbulent year marked by the rapid decline of its COVID business. During a four-hour investor event last week, Pfizer pushed its initative to “accelerate breakthroughs that help people with cancer globally live better and longer lives,” according to CNBC. The drugmaker has ramped...
